NURS FPX 4025 Assessment 1 Analysis of Article
Brennan and colleagues (2024) employed a qualitative systematic review in NURS FPX 4025 Assessment 1 to provide recommendations for the use of beta-blockers in patients with acute decompensated heart failure. This paper is a systematic review, as it examines academic literature supported by evidence within a specified time frame and then analyzes the results to conclude. The review has category 1.b since it includes randomized controlled trials and other kinds of research. The article under evaluation is credible for a number of reasons. In analyzing a research paper, an article was published Ochsner Journal, which is a peer-reviewed academic journal. In order to support their discussion and ideas, the authors of the developed article also cited thirty scholarly articles. Since it was only released in September 2024, this piece is still relevant even though it was written less than a year ago.
The use of beta-blockers in patients with heart failure (lower ejection fraction) who were admitted with acute decompensated heart disease is what Brennan and colleagues (2024) discuss in their research paper. Additionally, the researchers acknowledge that while beta-blocker use is generally high among heart failure patients, it is low among those admitted to hospitals with acute decompensated heart failure (Brennan et al., 2024). Through the article by Brennan and co-authors, a systematic review of studies from 2004 to 2024 was examined for this NURS FPX 4025 assessment 1. In patients with acute decompensated heart failure, the authors found that both starting and continuing beta-blocker medication improved patient outcomes (Brennan et al., 2024). This research paper example suggests an evidence-based guideline flowchart to assist clinicians in determining when to start and stop beta-blockers in patients with decompensated heart failure. This research paper enhances data that may be utilized to elucidate the
